Pat Cotroneo
Keine laufenden Positionen mehr
Profil
Zurzeit ist Pat Cotroneo Chief Financial Officer & Senior VP-Finance bei FibroGen, Inc. Zuvor war Pat Cotroneo als Controller bei Systemix, Inc. und als Controller bei Genetic Therapy, Inc. tätig. Er erhielt einen Bachelor-Abschluss von der University of San Francisco.
Ehemalige bekannte Positionen von Pat Cotroneo
| Unternehmen | Position | Ende |
|---|---|---|
| FIBROGEN, INC. | Director of Finance/CFO | 07.09.2021 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Comptroller/Controller/Auditor | 01.01.2000 |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Comptroller/Controller/Auditor | 01.01.2000 |
Ausbildung von Pat Cotroneo
| University of San Francisco | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Commercial Services |
